Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

accellix.com

Founded Year

2007

Stage

Private Equity - II | Alive

Total Raised

$32.25M

Last Raised

$10M | 10 mos ago

About Accellix

Accellix develops fully automated, cost-effective, actionable cell-based analysis, 24/7 at the point of need, to a broad range of users. Its Accellix single-use cartridge analysis system provides results in less than 30 minutes, requires minimal training, and does not require users to deal with biological reagents, sample preparation, and complex data analysis.

Accellix Headquarters Location

5 Shlomo Momo Halevi St. Har Hotzvim

Jerusalem,

Israel

+972-2-674-4422

ESPs containing Accellix

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTHMARKET STRENGTHLEADERHIGHFLIEROUTPERFORMERCHALLENGER
Life Sciences / Medical Devices Tech

Point-of-care (POC) testing refers to diagnostic lab tests that can be performed rapidly, reliably, and easily at or near the point of care. Starting with a biological sample, POC tests detect or quantify certain analytes — such as infectious agents, cardiac markers, and blood glucose — to inform clinical decision making.

Accellix named as Leader among 14 other companies, including Cepheid, Ellume, and Genalyte.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Accellix

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Accellix is included in 4 Expert Collections, including Medical Devices.

M

Medical Devices

8,732 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health Monitoring & Diagnostics

3,123 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

D

Digital Health

13,114 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

H

Health IT

7,901 items

Accellix Patents

Accellix has filed 15 patents.

The 3 most popular patent topics include:

  • Biotechnology
  • Blood tests
  • Chemical tests
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/14/2019

10/20/2020

Flow cytometry, Microscopy, Cell biology, Dosage forms, Image processing

Grant

Application Date

11/14/2019

Grant Date

10/20/2020

Title

Related Topics

Flow cytometry, Microscopy, Cell biology, Dosage forms, Image processing

Status

Grant

Latest Accellix News

10:45 EDT Regenerative Medicine Partnering Report 2022 - Trends in Regenerative Medicine Dealmaking in the Biopharma Industry Si...

Aug 19, 2022

News provided by Share this article Share this article This report is intended to provide the reader with an in-depth understanding and access to Regenerative Medicine trends and structure of deals entered into by leading companies worldwide. Regenerative Medicine Partnering Terms and Agreements includes: Trends in Regenerative Medicine dealmaking in the biopharma industry since 2015 Access to headline, upfront, milestone and royalty data Access to Regenerative Medicine contract documents Leading Regenerative Medicine deals by value since 2015 Most active Regenerative Medicine dealmakers since 2015 In Global Regenerative Medicine Partnering Terms and Agreements 2015-2022, the available deals are listed by: Company A-Z Deal component type Technology type Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand. The Global Regenerative Medicine Partnering terms and Agreements 2015-2022 report provides comprehensive access to available deals and contract documents for over 1600 Regenerative Medicine deals. Analyzing actual contract agreements allows assessment of the following: What are the precise rights granted or optioned? What is actually granted by the agreement to the partner company? What exclusivity is granted? How are sales and payments audited? What is the deal term? How are the key terms of the agreement defined? How are IPRs handled and owned? Who is responsible for commercialization? Who is responsible for development, supply, and manufacture? How is confidentiality and publication managed? How are disputes to be resolved? Under what conditions can the deal be terminated? What happens when there is a change of ownership? What sublicensing and subcontracting provisions have been agreed? Which boilerplate clauses does the company insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for agreement law? Companies Mentioned Technology and Research A*STAR' Institute of Molecular and Cell Biology A2 Biotherapeutics Abveris Accellix

Accellix Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Accellix Rank

  • When was Accellix founded?

    Accellix was founded in 2007.

  • Where is Accellix's headquarters?

    Accellix's headquarters is located at 5 Shlomo Momo Halevi St., Jerusalem.

  • What is Accellix's latest funding round?

    Accellix's latest funding round is Private Equity - II.

  • How much did Accellix raise?

    Accellix raised a total of $32.25M.

  • Who are the investors of Accellix?

    Investors of Accellix include BroadOak Capital Partners, bioMerieux and Axcel Partners.

  • Who are Accellix's competitors?

    Competitors of Accellix include Visby Medical, Baebies, Cardea Bio, MeMed, Inflammatix, Oxford Nanopore Technologies, LumiraDx, Cue Health, Roche Holding, Cepheid and 22 more.

You May Also Like

Inflammatix Logo
Inflammatix

Inflammatix is a molecular diagnostics company that develops rapid tests that read the immune system to resolve major clinical and public health challenges. The company's initial focus is on acute bacterial, viral infections, and sepsis.

Torus Biosystems Logo
Torus Biosystems

Torus Biosystems performs testing of DNA for scientific and medical research purposes.

S
Sight Diagnostics

Sight Diagnostics provides affordable and accurate diagnostics in a compact platform designed for use in qualified labs in low volume settings. Its proprietary machine-vision based technology provides the capability to perform multiple tests on a single, easy-to-operate platform.

Ellume Logo
Ellume

Ellume is a digital diagnostics company that develops and commercializes connected products for healthcare professionals and consumers. The company has developed a new biosensor technology that features unique optoelectronics and biologics.

Weavr Health Logo
Weavr Health

Weavr Health is dedicated to connecting people to health by simplifying sample collection and processing for healthcare.The Velvet device is designed so anyone, anywhere can easily collect high-quality samples without a phlebotomist. The Velvet device offers a smooth experience of blood self-collection for patients. It leverages a similar experience to traditional glucose testing, which >25% of people have experienced. Each device arrives with all that is needed to collect, package and ship quality samples to the lab for a convenient experience.

Binx Health Logo
Binx Health

Binx Health is an in vitro diagnostics Point-of-Care (POC) company that provides at-home STI testing. The platform also includes evidence-based testing, counseling, treatment, and follow up in order to increase screening and reduce infections.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.